Latest Insider Transactions at Colgate Palmolive CO (CL)
This section provides a real-time view of insider transactions for Colgate Palmolive CO (CL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of COLGATE PALMOLIVE CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of COLGATE PALMOLIVE CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Patricia Verduin SVP, Global Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
49,069
+30.97%
|
$3,582,037
$73.0 P/Share
|
|
Aug 04
2022
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
51,665
-18.89%
|
$4,184,865
$81.27 P/Share
|
|
Aug 04
2022
|
Noel R. Wallace Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,665
+15.89%
|
$3,719,880
$72.99 P/Share
|
|
Aug 04
2022
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
24,703
-33.9%
|
$2,000,943
$81.25 P/Share
|
|
Aug 04
2022
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
24,703
+25.32%
|
$1,803,319
$73.0 P/Share
|
|
Jul 01
2022
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
273
+1.01%
|
$21,021
$77.62 P/Share
|
|
Jul 01
2022
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
273
+1.08%
|
$21,021
$77.62 P/Share
|
|
Jun 06
2022
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
50,000
-18.4%
|
$3,950,000
$79.34 P/Share
|
|
Jun 06
2022
|
Noel R. Wallace Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+15.54%
|
$3,600,000
$72.99 P/Share
|
|
May 16
2022
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
19,683
-73.75%
|
$1,535,274
$78.49 P/Share
|
|
May 16
2022
|
John W Kooyman Chief of Staff |
BUY
Exercise of conversion of derivative security
|
Direct |
19,683
+42.45%
|
$1,417,176
$72.99 P/Share
|
|
May 16
2022
|
Philip G. Shotts Vice President and Controller |
SELL
Open market or private sale
|
Direct |
10,000
-17.83%
|
$780,000
$78.52 P/Share
|
|
May 16
2022
|
Philip G. Shotts Vice President and Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+15.13%
|
$720,000
$72.99 P/Share
|
|
May 11
2022
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
2,600
-27.16%
|
$200,200
$77.06 P/Share
|
|
May 09
2022
|
John T Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+8.15%
|
-
|
|
May 09
2022
|
Kimberly A Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+44.06%
|
-
|
|
May 09
2022
|
Stephen I Sadove Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,317
+20.08%
|
-
|
|
May 09
2022
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+8.62%
|
-
|
|
May 09
2022
|
Michael B Polk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+9.0%
|
-
|
|
May 09
2022
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,738
+20.18%
|
-
|
|
May 09
2022
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+12.02%
|
-
|
|
May 09
2022
|
Martina Hundmejean Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+27.37%
|
-
|
|
May 09
2022
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+8.12%
|
-
|
|
Apr 01
2022
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+1.17%
|
$21,225
$75.16 P/Share
|
|
Apr 01
2022
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+1.26%
|
$21,225
$75.16 P/Share
|
|
Feb 18
2022
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
8,812
-15.48%
|
$696,148
$79.25 P/Share
|
|
Feb 18
2022
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
38,583
-14.83%
|
$3,048,057
$79.33 P/Share
|
|
Feb 18
2022
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
3,023
-24.0%
|
$238,817
$79.22 P/Share
|
|
Feb 18
2022
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,624
-16.02%
|
$128,296
$79.17 P/Share
|
|
Feb 18
2022
|
Philip G. Shotts Vice President and Controller |
SELL
Open market or private sale
|
Direct |
2,461
-5.07%
|
$194,419
$79.19 P/Share
|
|
Feb 18
2022
|
Patricia Verduin SVP, Global Technology |
SELL
Open market or private sale
|
Direct |
6,306
-9.48%
|
$498,174
$79.28 P/Share
|
|
Feb 17
2022
|
Prabha Parameswaran Vice Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
5,043
-26.32%
|
$398,397
$79.15 P/Share
|
|
Feb 17
2022
|
Prabha Parameswaran Vice Chair |
BUY
Grant, award, or other acquisition
|
Direct |
12,450
+39.39%
|
-
|
|
Feb 17
2022
|
Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin |
SELL
Payment of exercise price or tax liability
|
Direct |
5,804
-27.54%
|
$458,516
$79.15 P/Share
|
|
Feb 17
2022
|
Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin |
BUY
Grant, award, or other acquisition
|
Direct |
14,332
+40.48%
|
-
|
|
Feb 17
2022
|
Jennifer Daniels CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
16,797
+22.78%
|
-
|
|
Feb 17
2022
|
Noel R. Wallace Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
73,562
+22.04%
|
-
|
|
Feb 17
2022
|
John W Kooyman Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
5,660
+31.01%
|
-
|
|
Feb 17
2022
|
Sally Massey Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,764
+21.42%
|
-
|
|
Feb 17
2022
|
Philip G. Shotts Vice President and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
4,605
+8.66%
|
-
|
|
Feb 17
2022
|
Patricia Verduin SVP, Global Technology |
BUY
Grant, award, or other acquisition
|
Direct |
12,450
+15.76%
|
-
|
|
Feb 14
2022
|
John P Bilbrey Director |
SELL
Open market or private sale
|
Direct |
4,917
-18.37%
|
$383,526
$78.66 P/Share
|
|
Feb 14
2022
|
John P Bilbrey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,389
+16.76%
|
$382,619
$71.76 P/Share
|
|
Feb 09
2022
|
Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin |
SELL
Open market or private sale
|
Direct |
25,000
-78.86%
|
$2,025,000
$81.0 P/Share
|
|
Feb 09
2022
|
Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+44.09%
|
$1,800,000
$72.99 P/Share
|
|
Feb 03
2022
|
John T Cahill Director |
SELL
Open market or private sale
|
Direct |
5,389
-18.55%
|
$447,287
$83.16 P/Share
|
|
Feb 03
2022
|
John T Cahill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,389
+15.65%
|
$382,619
$71.76 P/Share
|
|
Feb 03
2022
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
40,580
-50.3%
|
$3,327,560
$82.93 P/Share
|
|
Feb 03
2022
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
40,580
+33.47%
|
$2,921,760
$72.99 P/Share
|
|
Feb 02
2022
|
Stephen I Sadove Director |
SELL
Bona fide gift
|
Indirect |
13,000
-100.0%
|
-
|